Literature DB >> 3486824

Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.

V V Micusan, G Mercier, A R Bhatti, R F Reiser, M S Bergdoll, D Oth.   

Abstract

Toxic shock syndrome toxin-1 (TSST-1), isolated from Staphylococcus aureus strains associated with toxic shock syndrome (TSS), is known as a potent mitogen and interleukin-1 inducer. The potential of TSST-1 as an interleukin-2 (IL-2) inducer was tested on human peripheral blood lymphocytes (HPBL) and murine spleen lymphocytes (MSL). These cells were incubated with TSST-1 and the supernatants analysed for IL-2 production. Preincubation of IL-2-dependent indicator cells (IC) with a monoclonal antibody specific for murine IL-2 receptors inhibited their proliferation by supernatants of TSST-1-treated MSL, thus strongly suggesting that they contain IL-2. The concentrations of TSST-1 required for HPBL or MSL to produce IL-2 ranged between 10(-1) and 10(-4) micrograms/ml. The amount of IL-2 units/ml varied little from one experiment to another. In contrast, IL-2 production by PHA-stimulated HPBL or Con A-stimulated MSL showed great variability and dependence on mitogen concentration. T-cell depleted MSL exposed to TSST-1 produced less IL-2. Experiments with germ-free mice and TSST-1-primed mice demonstrated that IL-2 production is not related to TSST-1 antigenicity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486824      PMCID: PMC1452667     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  T-cell growth factor-mediated T-cell proliferation.

Authors:  K A Smith; S Gillis; P E Baker; D McKenzie; F W Ruscetti
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

Review 2.  Phytohemagglutin and concanavalin A: probes for murine 'T' cell activivation and differentiation.

Authors:  J D Stobo
Journal:  Transplant Rev       Date:  1972

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

Review 4.  T-cell growth factor and the culture of cloned functional T cells.

Authors:  K A Smith; F W Ruscetti
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

5.  An improved assay for interleukin 2 (lymphocyte growth factor) produced by mitogen-activated lymphocytes.

Authors:  K J Lafferty; S J Prowse; A Al-Adra; H S Warren; J Vasalli; E Reich
Journal:  Aust J Exp Biol Med Sci       Date:  1980-12

Review 6.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

7.  Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes.

Authors:  M P Langford; G J Stanton; H M Johnson
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

8.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

9.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

10.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

View more
  10 in total

1.  Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.

Authors:  T Uchiyama; S Saito; H Inoko; X J Yan; K Imanishi; M Araake; H Igarashi
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Postoperative enteritis caused by methicillin-resistant Staphylococcus aureus.

Authors:  T Kodama; T Santo; T Yokoyama; Y Takesue; E Hiyama; Y Imamura; Y Murakami; H Tsumura; K Shinbara; N Tatsumoto; Y Matsuura
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.

Authors:  T Uchiyama; Y Kamagata; X J Yan; A Kawachi; H Fujikawa; H Igarashi; M Okubo
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

Review 4.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

5.  Clostridium perfringens enterotoxin lacks superantigenic activity but induces an interleukin-6 response from human peripheral blood mononuclear cells.

Authors:  T Krakauer; B Fleischer; D L Stevens; B A McClane; B G Stiles
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria.

Authors:  T Calandra; L A Spiegel; C N Metz; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

7.  Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.

Authors:  M Trudel; E J Stott; G Taylor; D Oth; G Mercier; F Nadon; C Séguin; C Simard; M Lacroix
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.

Authors:  B G Stiles; T Krakauer; P F Bonventre
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation.

Authors:  C M Cullen; L R Blanco; P F Bonventre; E Choi
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

10.  Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.

Authors:  T Uchiyama; Y Kamagata; X J Yan; M Kohno; M Yoshioka; H Fujikawa; H Igarashi; M Okubo; F Awano; T Saito-Taki
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.